print

Publications

International publications

van Balkom AJ, van Boeijen CA, Boeke AJ, van Oppen P, Kempe PT, van Dyck R.Comorbid depression, but not comorbid anxiety disorders, predicts poor outcome in anxiety disorders.Depress Anxiety. 2008 (in press).

Anholt GE, Kempe P, de Haan E, van Oppen P, Cath DC, Smit JH, van Balkom AJLM. Cognitive versus Behavior Therapy: Processes of Change in the Treatment of Obsessive-Compulsive Disorder. Psychother Psychosom 2008; 77: 38–42.

Greeven A, van Balkom AJLM, Visser S, Merkelbach JW, van Rood YR, van Dyck R, van der Does AJ, Zitman FG, Spinhoven P. Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial. Am J Psychiatry. 2007; 164: 91-99.

Kempe PT, van Oppen P, de Haan E, Twisk JW, Sluis A, Smit JH, van Dyck R, van Balkom AJ. Predictors of course in obsessive-compulsive disorder: logistic regression versus Cox regression for recurrent events. Acta Psychiatr Scand. 2007; 116: 201-10.

Batelaan N, de Graaf R, van Balkom A, Vollebergh W, Beekman A. Thresholds for health and thresholds for illness: panic disorder versus subthreshold panic disorder. Psychol Med. 2007; 37: 247-56.

de Jonge JL, Cath DC, van Balkom AJ. Quetiapine in patients with Tourette's disorder: an open-label, flexible-dose study. J Clin Psychiatry. 2007; 68: 1148-50.

Dusseldorp E, Spinhoven P, Bakker A, van Dyck R, van Balkom AJLM. Which panic disorder patients benefit from which treatment: cognitive therapy or antidepressants? Psychother Psychosom. 2007; 76:154-61.

Greeven A, van Balkom AJLM, van Rood YR, van Oppen P, Spinhoven P. The boundary between hypochondriasis and obsessive-compulsive disorder: a cross-sectional study from the Netherlands. Journal of Clinical Psychiatry 2006; 67 (11): 1682-9.

van Oppen P, van Balkom AJLM, de Haan E, van Dyck R. Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in OCD: A 5-year follow-up. Journal of Clinical Psychiatry 2005; 66: 1415-1422.

Anholt GE, Cath DC, Emmelkamp PM, van Oppen P, Smit JH, van Balkom AJLM. Do obsessional beliefs discriminate OCD without tic patients from OCD with tic and Tourette's syndrome patients? Behaviour Research and Therapy 2006; 44:1537-1543.

Loebach Wetherell J, Maser JD, van Balkom AJLM. Anxiety disorders in the elderly: outdated beliefs and a research agenda. Acta Psychiatrica Scandinavica 2005; 111: 401-402.

Bakker A, van Balkom AJLM, Stein DJ. Evidence-based pharmacotherapy of panic disorder. Int J Neuropsychopharmacol 2005; 30: 1-10.

Oude Voshaar RC, van Balkom AJLM, Zitman FG. Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study. European Neuropsychopharmacology 2004; 14: 301-306.

Oosterbaan DB, van Balkom AJLM, van Boeijen CA, de Meij TGJ, van Dyck R. An open study of paroxetine in hypochondriasis. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2001; 25: 1023-1033.

Bakker A, van Balkom AJLM, Spinhoven Ph. SSRI’s vs. TCA’s in the treatment of panic disorder: A meta-analysis. Acta Psychiatrica Scandinavica 2002; 106: 163 167.

Oosterbaan DB, van Balkom AJLM, Spinhoven Ph, de Meij TGJ, van Dyck R. The influence on treatment gain of comorbid avoidant personality disorder in patients with social phobia. Journal of Nervous and Mental Disease 2002; 190: 41-43.

Oosterbaan DB, van Balkom AJLM, Spinhoven Ph, van Oppen P, van Dyck R. Cognitive therapy versus moclobemide in social phobia: A controlled study. Clinical Psychology and Psychotherapy. 2001; 8: 263 273.

Oosterbaan DB, van Balkom AJLM, Spinhoven Ph, van Dyck R. The placebo response in social phobia. Journal of Clinical Psychopharmacology 2001; 15: 199 203.

van Balkom AJLM, Spinhoven Ph, Bakker A, Rammeloo KC, Graatsma AT, Adriaanse MTh, van Dyck R. Panic-free status is not associated with improvement on continuous measures in panic disorder. Journal of Nervous and Mental Disease 2000; 188: 840 842.

van der Linden GJH, Stein DJ, van Balkom AJLM. The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder: a meta-analysis of randomized controlled trials. International Clinical Psychopharmacology 2000; 15 (suppl 2): S15-S25.

van Balkom AJLM, Beekman ATF, de Beurs E, Deeg DJH, van Dyck R, van Tilburg W. Comorbidity of the anxiety disorders in a community based older population in The Netherlands. Acta Psychiatrica Scandinavica 2000; 101: 37 45.

Bakker A, van Balkom AJLM, van Dyck R. Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia. International Clinical Psychopharmacology 2000; 15 (suppl 2): S25-S31.